Therapy with canakinumab for gout by M. S. Eliseev, E. L. Nasonov

Subjects: Get full text

EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT by Maksim Sergeyevna Eliseev, O V Zhelyabin, V G Barskova, E L Nasonov

Subjects: Get full text

CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by R. V. Denisova, E. I. Alexeeva, T. V. Sleptsova

Subjects: Get full text

CLINICAL CASE: USE OF CANAKINUMAB IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RESISTANT TO IMMUNOSUPPRESSANTS AND GENETICALLY ENGINEERED BIOPHARMACEUTICALS by E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova, T. M. Bzarova, K. B. Isaeva, E. V. Mitenko, E. G. Chistyakova, A. M. Chomakhidze, N. I. Taybulatov, A. N. Fetisova, O. L. Lomakina, S. I. Valieva

Subjects: Get full text

EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME by Tatyana V. Sleptsova, Еkaterina I. Alexeeva, Тatyana М. Bzarova, Kirill V. Savostyanov, Аlexander A. Pushkov, Kseniya B. Isaeva, Rina V. Denisova, Оlga L. Lomakina

Subjects: Get full text

The role of interleukin 1 in the development of human diseases by E. L. Nasonov

Subjects: Get full text

Assessing Efficacy of Interleukin-1 Blockade in Patients with Alcoholic Hepatitis: A Comprehensive Systematic Review of Emerging Evidence by Shree Rath, Mary Girgis, Ishita Gupta, Anchit Chauhan, Zahir Ud Din, Hema Hotchandani, Ali Hasan, Raheel Ahmed, Raheel Qureshi

Subjects: Get full text

Canakinumab for the management of pyoderma gangrenosum: a case series of two patients and literature review by Howard Jie Yang, William Spratt, Francis Yi Xing Lai, Senhong Lee

Subjects: Get full text

Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS) by Weidong Zhang, Yunzhou Chen, Zeyu Yao, Mengling Ouyang, Minghui Sun, Shupeng Zou

Subjects: Get full text

Therapy with canakinumab for adult-onset still's disease by E. L. Nasonov

Subjects: Get full text

Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases by Mustafa Çakan, Şerife Gül Karadağ, Nuray Aktay Ayaz

Subjects: Get full text

Schnitzler Syndrome: An Under-Recognised Cause of Pyrexia of Unknown Origin by Dennis Tin Ho Chan, Ling Yin Ho

Subjects: Get full text

Is Canakinumab Safe During Pregnancy? New Insights from Three Cases in Slovakia by Branislav Slenker, Katarina Hrubiskova, Lenka Kapustova, Anna Bobcakova, Juraj Ondris, Milos Jesenak

Subjects: Get full text

Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol... by M. S. Eliseev, O. V. Zhelyabina, M. V. Mukagova, E. L. Nasonov

Subjects: “…interleukin (il) 1β inhibitor canakinumab…”
Get full text

Clinical and Genetic Characteristics, Target Therapy Results in Children with Traps Syndrome (on Clinical Surveillance Data) by E. V. Antsiferova, T. V. Cherkashina, N. G. Wolf, I. Yu. Naumenko, E. A. Anikina, N. G. Kiseleva, N. Yu. Makarevskaya, T. E. Taranushenko, L. N. Antsiferova, E. Yu. Emelyanchik

Subjects: Get full text

Adult Still's disease: New horizons by E. L. Nasonov, E. Feist

Subjects: Get full text

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC by Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer

Subjects: “…Canakinumab…”
Get full text

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY by E. L. Nasonov, T. V. Popkova

Subjects: Get full text

Tuberculosis risk in the biologic era: tuberculin skin test conversion rates in children with rheumatologic diseases by Canan Özlü, Serkan Türkuçar, Hatice Karaoğlu Asrak, Hatice Adıgüzel Dündar, Şevket Erbil Ünsal, Nurşen Belet

Subjects: Get full text

EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID) by T. V. Sleptsova, E. I. Alexeeva, K. V. Savost’yanov, A. A. Pushkov, A. G. Nikitin, T. M. Bzarova, S. I. Valieva, A. N. Fetisova, A. V. Pakhomov, N. V. Zhurkova, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova

Subjects: Get full text